Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma clinical trial (NCT04431089). Contact the study team or your healthcare provider for specific answers.

Question 2

How does SHC014748M compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma clinical trial (NCT04431089). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma clinical trial (NCT04431089). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific side effects I should be aware of with SHC014748M?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma clinical trial (NCT04431089). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma clinical trial (NCT04431089). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my participation in this trial affect my ongoing cancer treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma clinical trial (NCT04431089). Contact the study team or your healthcare provider for specific answers.

What this study is about